成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Cureus >>article

Cureus

IF: 1
Download PDF

Effectiveness of Rifaximin on the Outcomes of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published:6 September 2023 DOI: 10.7759/cureus.44807 PMID: 37809182
Zarghuna Khan,?Saad Khalid Khan,?Ibrahim Reyaz,?Hemalatha Anam,?Osama Ijaz,?Ilqa Attique,?Zoha Shahzad,?Faraz Saleem

Abstract

Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder that impacts the lives of many individuals worldwide. We conducted a systemic review and meta-analysis of randomized controlled trials (RCTs) to assess both the effectiveness of rifaximin in alleviating IBS symptoms and its potential adverse effects. PubMed, Web of Science, Embase, the Cochrane Library, Scopus, and Google Scholar were searched from inception until August 20, 2023, for studies comparing rifaximin with placebo in the resolution of symptoms among IBS patients. Risk ratios (RRs) and their corresponding 95% confidence intervals (CIs) were derived for all the outcomes of interest. Six RCTs were pooled in this analysis. The results showed improved abdominal distension with rifaximin over the control group. Overall symptom relief at the end of the treatment period and follow-up period was also observed in the patients receiving rifaximin. However, no significant differences were found between the rifaximin group and the control group for the outcomes of abdominal pain, nausea, headache, vomiting, diarrhea, sinusitis, bronchitis, and upper respiratory tract infection. The results of our meta-analysis support the use of rifaximin in the treatment of IBS, owing to its safety and effectiveness. Future RCTs should be conducted to assess this topic of interest more extensively.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Rifaximin 80621-81-4 C43H51N3O11 494 suppliers $39.00-$1200.00

Similar articles

IF:2.1

Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.

American Journal of Health-System Pharmacy Bryan L Love, Audrey Johnson,etc Published: 1 July 2014
IF:2.5

Effectiveness of prednisolone in complex regional pain syndrome treatment: A systematic narrative review.

Pain Practice Sang Gyu Kwak, Yoo Jin Choo,etc Published: 1 March 2022